Inhaltsbereich
| 17992 Einträge | « ‹ 845, 846, 847, 848, 849, 850, 851, 852, 853, 854, 855, 856, 857, 858, 859, 860, 861, 862, 863 › » |
Seite 854 / 900
 Druckansicht
|
| Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives-a meeting report. |
| Pinto C, Bergmann M, Briukhovetska D, Nuessler V, Sznol M, von Bergwelt-Baildon M, Kobold S |
| Journal for immunotherapy of cancer. pii: jitc-2019-000268. doi: 10.1136/jitc-2019-000268 |
| PMID: 32114499 |
| Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in mice. |
| Wressnigg N, Shurygina AP, Wolff T, Redlberger-Fritz M, Popow-Kraupp T, Muster T, Egorov A, Kittel C |
| The Journal of general virology. doi: 10.1099/vir.0.006122-0 |
| PMID: 19141445 |
| Teodora Krajewska, Official Female Doctor of Tuzla and Sarajevo: Medical Practitioner, Woman of Science, Polish Patriot and Feminist. |
| Fuchs B, Tahirović H |
| Acta medica academica. pii: ama2006-124.274. doi: 10.5644/ama2006-124.274 |
| PMID: 32124632 |
| Preface: More than two decades of modern tumor immunology. |
| Galluzzi L, Rudqvist NP |
| Methods in enzymology. pii: S0076-6879(20)30077-X. doi: 10.1016/S0076-6879(20)30077-X |
| PMID: 32122557 |
| Recommended electron-impact excitation and ionization cross sections for Be I. |
| Dipti, Das T, Bartschat K, Bray I, Fursa DV, Zatsarinny O, Ballance C, Chung HK, Ralchenko Y |
| Atomic data and nuclear data tables. doi: 10.1016/j.adt.2018.11.001. pmc: PMC7047829 |
| PMID: 32116394 |
| Standards for the assay of Creutzfeldt-Jakob disease specimens. |
| Minor P, Newham J, Jones N, Bergeron C, Gregori L, Asher D, van Engelenburg F, Stroebel T, Vey M, Barnard G, Head M, The Who Working Group On International Reference Materials For The Diagnosis And Study Of Transmissible Spongiform Encephalopathies |
| The Journal of general virology. doi: 10.1099/vir.0.79959-0 |
| PMID: 15166463 |
| PP2A Phospho-Tyr Antibodies Are Not Specific for this Modification but Are Sensitive to Other PP2A Modifications Including Leu Methylation. |
| Frohner IE, Mudrak I, Schüchner S, Anrather D, Hartl M, Sontag JM, Sontag E, Wadzinski BE, Preglej T, Ellmeier W, Ogris E |
| Cell reports. pii: S2211-1247(20)30196-0. doi: 10.1016/j.celrep.2020.02.035 |
| PMID: 32130916 |
| Direct interplay between stereochemistry and conformational preferences in aminoacylated oligoribonucleotides. |
| Polyansky AA, Kreuter M, Sutherland JD, Zagrovic B |
| Nucleic acids research. pii: 5587633. doi: 10.1093/nar/gkz902. pmc: PMC6868383 |
| PMID: 31612955 |
| Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer. |
| Westerveld H, Nesvacil N, Fokdal L, Chargari C, Schmid MP, Milosevic M, Mahantshetty UM, Nout RA |
| The Lancet. Oncology. pii: S1470-2045(19)30855-1. doi: 10.1016/S1470-2045(19)30855-1 |
| PMID: 32135119 |
| Brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial. |
| Califano R, Hochmair MJ, Gridelli C, Delmonte A, Garcia Campelo MR, Bearz A, Griesinger F, Morabito A, Felip E, Ghosh S, Tiseo M, Haney J, Kerstein D, Popat S, Camidge DR |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)30055-9. doi: 10.1093/annonc/mdz063.004 |
| PMID: 32131249 |
| Afatinib in EGFR TKI-naïve patients (pts) with locally advanced/metastatic NSCLC harbouring EGFR mutations: An interim analysis of a phase IIIB trial. |
| Passaro A, Laktionov KK, Poltoratskiy A, Egorova I, Hochmair M, Migliorino MR, Metro G, Gottfried M, Tsoi D, Ostoros G, Rizzato S, Mukhametshina GZ, Schumacher M, Novello S, Dziadziuszko R, Tang W, Clementi L, Cseh A, Kowalski D, De Marinis F |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)30064-X. doi: 10.1093/annonc/mdz063.013 |
| PMID: 32131245 |
| Genetic clustering of Borna disease virus natural animal isolates, laboratory and vaccine strains strongly reflects their regional geographical origin. |
| Kolodziejek J, Dürrwald R, Herzog S, Ehrensperger F, Lussy H, Nowotny N |
| The Journal of general virology. doi: 10.1099/vir.0.80587-0 |
| PMID: 15659758 |
| Prevention and management of osteoporotic fractures by non-physician health professionals: a systematic literature review to inform EULAR points to consider. |
| Wilson N, Hurkmans E, Adams J, Bakkers M, Balážová P, Baxter M, Blavnsfeldt AB, Briot K, Chiari C, Cooper C, Dragoi R, Gäbler G, Lems W, Mosor E, Pais S, Simon C, Studenic P, Tilley S, de la Torre J, Stamm TA |
| RMD open. pii: rmdopen-2019-001143. doi: 10.1136/rmdopen-2019-001143 |
| PMID: 32144136 |
| Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial. |
| Popat S, Kim HR, Ahn MJ, Yang JC, Han JY, Hochmair MJ, Lee KH, Delmonte A, Garcia Campelo MR, Kim DW, Griesinger F, Felip E, Califano R, Spira AI, Gettinger S, Tiseo M, Haney J, Kerstein D, Camidge DR |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)50461-6. doi: 10.1093/annonc/mdy424.070 |
| PMID: 32138039 |
| KEYNOTE-048: Phase III study of first-line pembrolizumab (P) for recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). |
| Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, De Castro G, Psyrri A, Baste Rotllan N, Neupane PC, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Roy A, Cheng J, Jin F, Rischin D |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)50436-7. doi: 10.1093/annonc/mdy424.045 |
| PMID: 32138007 |
| JAVELIN renal 101: A randomized, phase III study of avelumab + axitinib vs sunitinib as first-line treatment of advanced renal cell carcinoma (aRCC). |
| Motzer RJ, Penkov K, Haanen JBAG, Rini BI, Albiges L, Campbell MT, Kollmannsberger CK, Negrier S, Uemura M, Lee JL, Gurney H, Berger R, Schmidinger M, Larkin J, Atkins MB, Wang J, Robbins PB, Chudnovsky A, Di Pietro A, Choueiri TK |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)50427-6. doi: 10.1093/annonc/mdy424.036 |
| PMID: 32137998 |
| Updated efficacy and safety data of dabrafenib (D) and trametinib (T) in patients (pts) with BRAF V600E-mutated anaplastic thyroid cancer (ATC). |
| Keam B, Kreitman RJ, Wainberg ZA, Cabanillas ME, Cho DC, Italiano A, Stein A, Cho JY, Schellens JHM, Wen PY, Zielinski CC, Boran AD, Mookerjee B, Burgess P, Rangwala F, Subbiah V |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)50260-5. doi: 10.1093/annonc/mdy302.002 |
| PMID: 32137753 |
| Prospective observational study to evaluate the persistence of treatment with denosumab (dmab) in patients (pts) with bone metastases (BM) from solid tumors (ST) in routine clinical practice: Final analysis. |
| Haslbauer F, Petzer AL, Safanda M, Tomova A, Porubska M, Bajory Z, Niepel D, Jäger C, Kalinin D, Greil R |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)50227-7. doi: 10.1093/annonc/mdy300.102 |
| PMID: 32137717 |
| Use of lipegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia: Pan-European non-interventional study. |
| Steger G, Pichler P, Airoldi M, Mazza P, Fontaine C, Timmer Bonte J, Walewski JA, Katolicka J, Mikulova M, Gasparic M |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)50139-9. doi: 10.1093/annonc/mdy300.014 |
| PMID: 32137621 |
| Outcome following unplanned excision in soft tissue sarcoma: Results of a multicentre study including 728 patients. |
| Smolle MA, Tunn PU, Goldenitsch E, Posch F, Szkandera J, Bergovec M, Liegl-Atzwanger B, Leithner A |
| Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)50067-9. doi: 10.1093/annonc/mdy299.001 |
| PMID: 32137523 |
| 17992 Einträge | « ‹ 845, 846, 847, 848, 849, 850, 851, 852, 853, 854, 855, 856, 857, 858, 859, 860, 861, 862, 863 › » |
Seite 854 / 900
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
